Coca-Cola Europacific Partners: Easter bunny. dsm-firmenich: No Pin, No Gain. D'Ieteren: Belgian competitor Autoglass Clinic doubles in size since acquisition by Cary. PostNL: 1Q26 trading disappoints on weak volume trends; FY26 outlook reiterated. Theon International: Preview – up for a solid start
SUCCÈS DE L’ÉMISSION OBLIGATAIRE INAUGURALE VERTE DE 500 M€ D’ARGAN Communiqué de presse – Neuilly-sur-Seine, Jeudi 23 avril 2026 - 19h30 Succès de l’émission obligataire inaugurale verte de 500 M€ d’ARGAN ARGAN annonce le succès de son émission obligataire verte inaugurale d’un montant total de 500 millions d’euros, à échéance octobre 2029, assortie d’un coupon annuel de 3,779 % (soit une marge à MS + 100 points de base) en ligne avec les anticipations de la Société1 notamment partagées lors des résultats annuels 20252. Cette première émission verte, sursouscrite 5,5 fois, témoigne de ...
ARGAN SUCCESSFULLY PLACED AN INAUGURAL €500M GREEN BOND Press release – Neuilly-sur-Seine, Thursday, April 23, 2026 – 7.30pm ARGAN successfully placed an inaugural €500m green bond ARGAN today announced it successfully placed an inaugural 500 million euros green bond, maturing in October 2029, with an annual coupon of 3.779% (i.e., a margin of MS + 100 bps) in line with the company’s expectations1, as outlined in particular in its 2025 annual results2. This first green bond—5.5 times oversubscribed—demonstrates investors’ confidence in ARGAN’s strategy, the quality of its credit rating—B...
In this note we present our assessment of the two-day Capital Markets Day and update our model to reflect the €307m convertible bond issuance and the €10.0m increase in underlying EBITDA guidance communicated at the 1Q26 results. We view the EBITDA uplift as conservative. The convertible results in approximately €2.0/share dilution, including our updated treatment of the waiver amount related to the first convertible bond. Despite the extensive CMD, limited guidance was provided on the franchise...
AkzoNobel: 1Q26 beat and FY guidance maintained. ASM International: 1Q26 results, great start to the year. Basic-Fit: Highlights of Capital Markets Day 2026. BE Semiconductor Industries: 1Q26 Preview - building strength. Cofinimmo: Earnings beat, muted investments; Armonea agreement reached. Corbion: Not so sweet. MICC: Peer Danone 1Q26 results. Randstad: Slight beat on 1Q26, trends improving; 2Q26 guidance at least in line. Recticel: 1Q26 in line, sharp pick-up expected in 2Q. ...
UCB announced that it has entered into a definitive agreement to acquire Neurona Therapeutics, including lead epilepsy cell therapy asset NRTX-1001, for a $ 650m upfront and up to $ 500m in potential milestones. We're encouraged by NRTX-1001's phase 1/2 data showing approx. 80% reduction in disabling seizures at 4-6 months post administration in drug-resistant unilateral mesial temporal lobe epilepsy (MTLE), with or without mesial temporal sclerosis (MTS), and look forward to the phase 3 progra...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.